We are live on ! Find out more
BLFS icon

BioLife Solutions

15 hedge funds and large institutions have $558K invested in BioLife Solutions in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

29% more capital invested

Capital invested by funds: $431K → $558K (+$127K)

0.02% less ownership

Funds ownership: 2.08%2.06% (-0.02%)

21% less funds holding

Funds holding: 1915 (-4)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
15
Holders Change
-4
Holders Change %
-21.05%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

BLFS Hedge Fund Activity: Q1 2017 in Review

15 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2017, worth a combined $558K — up 29% from $431K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BLFS and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was BlackRock, opening a new position worth an estimated $69.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $27K sold.

  • 15 institutional investors held BioLife Solutions (BLFS) as of Q1 2017, down from 19 in Q4 2016.
  • Funds reported $558K of BioLife Solutions stock for Q1 2017, up 29% quarter-over-quarter.
  • 3 funds opened new BioLife Solutions positions in Q1 2017 and 5 closed out, a net change of -2 holders.
  • The largest BioLife Solutions buyer in Q1 2017 was BlackRock, an estimated $69.9K added.
  • The largest BioLife Solutions seller in Q1 2017 was Citadel Advisors, an estimated $27K sold.

Based on aggregated 13F filings for Q1 2017.